Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPOS vs GnRH Antagonist Protocol in Patients Undergoing PGT-A
NCT04414748Phase 3Completed
- Sponsor
- Shanghai Ji Ai Genetics & IVF Institute
- Start
- Jun 2020
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dydrogesterone in infertility (2 arms), sponsored by Shanghai Ji Ai Genetics & IVF Institute. Primary endpoint: Euploidy Rate of Blastocysts. Started Jun 2020; status: completed.
02
Drugs
dydrogesterone
03
Conditions
infertility
Beyond the preview
Go deeper on NCT04414748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04414748.